Conditions: Pain
Keywords: chronic pain joint pain back pain diabetic peripheral neuropathy post herpetic neuralgia ALO-01 Embeda Chronic Non-Malignant Pain
Allocation: NON_RANDOMIZED | Intervention model: SINGLE_GROUP
Enrollment: 467
Healthy volunteers: no

Brief summary:
Open-Label, Safety Study to evaluate the long-term safety of Kadian NT (ALO-01) administered for up to 12 months.

Detailed description:

Arms:
arm 1: Doses given once or twice daily

Interventions: intervention 1: ALO-01 (Morphine Sulfate Plus Naltrexone Hydrochloride ER)
Intervention descriptions: intervention 1: capsules, available dosage strengths 20, 30, 40, 50, 60, 80, and 100 mg morphine sulfate with 4% by weight naltrexone hydrochloride given once or twice daily

Protocol document: